A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinoma
We describe the safety profile and efficacy of IRE with nivolumab.
Source: Surgery - Category: Surgery Authors: Conor O ’Neill, Traci Hayat, John Hamm, Mary Healey, Qianqian Zheng, Yan Li, Robert C.G. Martin Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Immunotherapy | Pancreas | Pancreatic Cancer | Surgery